Highly Multiplexed Imaging in Immuno-Oncology
Fluidigm SPONSORED CONTENT

Highly Multiplexed Imaging in Immuno-Oncology

BlueskyReddit
March 18, 2020

Immuno-oncology is already saving some cancer patients, but there is still much progress to be made. Where cancer resists treatment or turns resistant over time, scientists need to better understand the molecular details of the disease and its interaction with treatments. To do so, they need tools that track many targets at once and in fine detail. A promising method uses Imaging Mass Cytometry (IMC), which provides high-dimensional, subcellular spatial and molecular information that is sufficiently high-resolution to precisely locate crucial molecular interactions in relation to a tumor and its surroundings.

Learn More